Thomas Neal, MD
Family Medicine · Coeur D Alene, IDNPI 1922079235
Payments from drug & device makers
Across 287 payments — averaging $12.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- AbbVie$585
- Amgen$288
- Lilly USA, LLC$227
- Johnson & Johnson$173
- Exact Sciences$137
- plus $1K from 27 others
What the payments were for
- Food & beverage$3,673100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 131 | $1,034 |
| AbbVie(2 entities) | 38 | $585 |
| Amgen(2 entities) | 23 | $288 |
| Lilly USA, LLC | 14 | $227 |
| Johnson & Johnson | 10 | $173 |
| Exact Sciences | 6 | $137 |
| Xeris Pharmaceuticals, Inc. | 5 | $134 |
| Pfizer | 5 | $115 |
| Novo Nordisk | 7 | $113 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $85 |
| AstraZeneca | 5 | $71 |
| Biohaven Pharmaceuticals, Inc. | 3 | $55 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $53 |
| Genentech USA, Inc. | 3 | $51 |
| Boston Scientific | 2 | $51 |
| Grifols USA, LLC | 2 | $48 |
| Dexcom, Inc. | 2 | $46 |
| Insulet Corporation | 2 | $45 |
| BETA Bionics, Inc. | 1 | $44 |
| Sunovion Pharmaceuticals Inc. | 4 | $42 |
| Eisai Inc. | 2 | $41 |
| Corcept Therapeutics | 2 | $36 |
| Edwards Lifesciences | 1 | $28 |
| Sanofi Pasteur Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Ironwood Pharmaceuticals, Inc | 1 | $16 |
| Medtronic | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
| Merck | 1 | $12 |
How this compares
$3,673 in reported general payments places this provider in the 90th percentile of 803 family medicine providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 70 | $62,424 |
| OzempicSemaglutide | 27 | $42,659 |
| MounjaroTirzepatide | 26 | $27,955 |
| JanuviaSitagliptin Phosphate | 30 | $23,095 |
| JardianceEmpagliflozin | 18 | $22,575 |
| TrulicityDulaglutide | 22 | $22,326 |
| XareltoRivaroxaban | 12 | $14,136 |
| Tresiba Flextouch U-100Insulin Degludec | 25 | $12,391 |
| Breo ElliptaFluticasone/Vilanterol | 28 | $11,111 |
| LinzessLinaclotide | 12 | $6,171 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 22 | $5,388 |
| Testosterone | 13 | $5,279 |
| Atorvastatin Calcium | 400 | $3,793 |
| SynthroidLevothyroxine Sodium | 68 | $3,781 |
| Levothyroxine Sodium | 305 | $3,320 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $115 | $62,42470 claims |
| Lilly USA, LLCMounjaro, Trulicity | $227 | $50,28148 claims |
| Novo NordiskOzempic | $113 | $42,65927 claims |
| MerckJanuvia | $12 | $23,09530 claims |
| Johnson & JohnsonXarelto | $173 | $14,13612 claims |
| GSKBreo Ellipta, Arnuity Ellipta | $1,034 | $14,04940 claims |
| AbbVieLinzess, Synthroid | $585 | $9,95280 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 803 family medicine providers in Idaho.
Other family medicine in Coeur D Alene
- Henry DownsCoeur D Alene$69K
- Crystal PyrakCoeur D Alene$46K
- Douglas LinfordCoeur D Alene$6K
- Mark TurnerMeridian$40.5M
- David ButukMeridian$15.2M
- Gary SoucieBlackfoot$5.8M
- Brock McConneheyBoise$4.5M
- William LaitinenMiddleton$1.1M
- Diane McConneheyBoise$681K
- Flint PackerIdaho Falls$587K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.